Member News
-
Valeo Pharma to Host First Quarter 2023 Results Conference Call / Webcast
March 9, 2023 (Source) – Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Visionstate Corp. Signs MOU with Fluido.ai to Explore AI Business Opportunities
March 9, 2023 (Source) – Visionstate Corp. (TSXV:VIS) (“Visionstate” or the “Company”) a leading provider of smart facility-management technology, today announced that…
-
Elcora Advanced Materials Corp. Proposes to Extend Warrants Expiry Date
March 8, 2023 (Source) – ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM | OTCQB – ECORF), (the “Company” or “Elcora”)…
-
Hemostemix Unit Offering Repriced
March 8, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) announces it is repricing its…
-
Energy Fuels Announces 2022 Results; Emerging as the Leading US Producer of Critical Minerals with Focus on Uranium and Rare Earth Elements
Webcast on March 10, 2023 Preparing multiple uranium mines for production, completing profitable sales & developing rare earth refining…
-
Kraken Energy to Present at the Kinvestor Green Future 2023 Virtual Investor Conference
March 8, 2023 (Source) – Kraken Energy Corp. (CSE: UUSA) (OTCQB: UUSAF) (the “Company” or “Kraken Energy”) is…
-
Crypto AM’s Founder & Editor-at-Large, James Bowater Joins Fineqia’s Advisory Board
March 8, 2023 (Source) – Fineqia International Inc. (the “Company” or “Fineqia”) (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA)…
-
Auxico Files Audited Financial Statements for the Year Ended September 30, 2022
March 7, 2023 (Source) – Auxico Resources Canada Inc. (CSE: AUAG) announces the filing of its audited annual financial statements…
-
Search Minerals to Receive $5 Million in funding from the Government of Canada under the Critical Minerals Research Development & Demonstration Program
March 7, 2023 (Source) – Search Minerals Inc. (“Search Minerals”) (TSXV: SMY | OTCQB: SHCMF) is pleased to announce…
-
Hemostemix Offers up to 500 6% Convertible Debentures, Convertible into an ACP-01 Therapeutic Production Slot that is Subject to Compassionate Exemption from Regulatory Approval
March 7, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“HEM” or the “Company”) is…
